Skip to main content
. 2017 Dec 20;12(12):e0189249. doi: 10.1371/journal.pone.0189249

Table 1. Overall details of the patients and differential characteristics of those that suffered LA.

Overall Details (n = 79) S.aureus-VAP Patients OR [95%CI] p values
Abcess (n = 10) NoAbcess (n = 69)
Male sex 67 (85) 10 (100) 57 (83) - 0.35
Age (y) 35 [21–64] 20 [17–32] 45 [23–67] - 0.004
Reasons for admission
 Trauma 49 (62) 9 (90) 40 (58) - 0.42
 Digestive surgery 5 (6) 0 5 (7)
 Vascular surgery 11 (14) 0 11 (16)
 Neurosurgery 7 (9) 1 (1) 6 (9)
 Medical 7 (9) 0 7 (10)
Underlying diseases
 COPD 3 (4) 0 3 (4) - 1
 Tobacco 17 (22) 1 (10) 10 (23) 0.37 [0.04–3.13] 0.68
 Immunodeficiency 2 53° 0 2 (3) - 1
 Diabetes mellitus 9 (11) 0 9 (13) - 0.59
 Chronic heart failure 11 (14) 0 11 (16) - 0.34
 Chronic renal failure 7 (9) 0 7 (10) - 0.59
Gravity score at admission
 SAPSII 42 [32–52] 45 [34–53] 42 [32–52] - 0.53
 GCS 8 [5–15] 5 [3–7] 9 [6–15] - 0.009
Length of ICU stay (d) 21 [9–29] 30 [19–45] 20 [8–28] - 0.038
Duration of ATB treatment 7 [5–10] 10 [7–12] 7 [5–8] 0.029
Clinical cure 47 (59) 7 (70) 40 (58) 1.69 [0.4–7.1] 0.73
Death 30 (38) 3 (30) 27 (39) 0.67 [0.16–2.8] 0.73

NOTE. Data are no. (%) or mean [Q1-Q3]. Statistical analysis was done comparing the two groups (Abscess vs no abscess). ASA, American society of anesthesia; ATB, antibiotics; COPD, chronic obstructive pulmonary disease; GCS, Glasgow coma scale; ICU, intensive care unit; LA, lung abscess; OR, odds ratio; SAPSII, simplified acute physiologic score